• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.

作者信息

Busch R, Strang G, Howland K, Rothbard J B

机构信息

Laboratory of Molecular Immunology, Imperial Cancer Research Fund, London, UK.

出版信息

Int Immunol. 1990;2(5):443-51. doi: 10.1093/intimm/2.5.443.

DOI:10.1093/intimm/2.5.443
PMID:1707655
Abstract

Binding of linear fragments of protein antigens to class I or class II molecules of the MHC is necessary for the stimulation of a cellular immune response. This report describes the binding of a biotinylated T cell determinant from influenza hemagglutinin to class II proteins on the surface of Epstein-Barr virus-transformed B lymphocytes. The rapid, simple, and quantitative binding assay involves flow cytometric analysis of transformed B cells stained with fluoresceinated streptavidin following incubation with the biotinylated peptide. Binding of the biotinylated peptide required cell surface expression of human class II molecules, and was inhibited by an anti-HLA-DR monoclonal antibody as well as the unbiotinylated natural determinant. Rates of association and dissociation of the peptide were similar to those reported for purified MHC class II proteins, and the peptide bound only approximately 1% of the DR molecules expressed on the cell surface. When assayed on many different DR-homozygous B cell lines, the biotinylated hemagglutinin T cell determinant bound to HLA-DR on each cell line. The degeneracy of peptide binding to B cell lines was not unique to the hemagglutinin peptide because three other biotinylated T cell determinants failed to bind to class II deficient B-lymphoblastoid cells but bound to varying degrees to multiple DR-homozygous lines.

摘要

相似文献

1
Degenerate binding of immunogenic peptides to HLA-DR proteins on B cell surfaces.
Int Immunol. 1990;2(5):443-51. doi: 10.1093/intimm/2.5.443.
2
Effect of natural polymorphism at residue 86 of the HLA-DR beta chain on peptide binding.HLA-DRβ链第86位残基自然多态性对肽结合的影响。
J Immunol. 1991 Aug 15;147(4):1292-8.
3
A recombinant single-chain human class II MHC molecule (HLA-DR1) as a covalently linked heterotrimer of alpha chain, beta chain, and antigenic peptide, with immunogenicity in vitro and reduced affinity for bacterial superantigens.一种重组单链人II类主要组织相容性复合体分子(HLA-DR1),作为α链、β链和抗原肽的共价连接异源三聚体,在体外具有免疫原性,且对细菌超抗原的亲和力降低。
Eur J Immunol. 1997 Aug;27(8):1933-41. doi: 10.1002/eji.1830270817.
4
Peptides recognized by class I restricted T cells also bind to MHC class II molecules.
Int Immunol. 1990;2(5):435-41. doi: 10.1093/intimm/2.5.435.
5
Masking of a cathepsin G cleavage site in vivo contributes to the proteolytic resistance of major histocompatibility complex class II molecules.体内半胱氨酸蛋白酶 G 裂解位点的掩蔽有助于主要组织相容性复合体 II 类分子的蛋白水解抗性。
Immunology. 2010 Jul;130(3):436-46. doi: 10.1111/j.1365-2567.2010.03247.x. Epub 2010 Mar 17.
6
Properties of HLA class II molecules divergently associated with Goodpasture's disease.与肺出血肾炎综合征呈不同关联的HLA II类分子特性。
Int Immunol. 2000 Aug;12(8):1135-43. doi: 10.1093/intimm/12.8.1135.
7
Antigen presentation mediated by recycling of surface HLA-DR molecules.
Nature. 1995 Jun 15;375(6532):603-6. doi: 10.1038/375603a0.
8
Conformational and structural characteristics of peptides binding to HLA-DR molecules.与HLA-DR分子结合的肽段的构象和结构特征。
J Immunol. 1991 Jul 1;147(1):189-97.
9
Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding.
EMBO J. 1990 Jun;9(6):1797-803. doi: 10.1002/j.1460-2075.1990.tb08304.x.
10
Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.主要组织相容性复合体分子和肽的分子模拟可解释一些同种异体反应。
Immunol Lett. 1992 Sep;34(1):63-9. doi: 10.1016/0165-2478(92)90028-m.

引用本文的文献

1
Gold Nanoparticles as a Platform for Delivery of Immunogenic Peptides to THP-1 Derived Macrophages: Insights into Nanotoxicity.金纳米颗粒作为将免疫原性肽递送至THP-1衍生巨噬细胞的平台:对纳米毒性的见解
Vaccines (Basel). 2025 Jan 24;13(2):119. doi: 10.3390/vaccines13020119.
2
HLA Class II Genotype Does Not Affect the Myelin Responsiveness of Multiple Sclerosis Patients.人类白细胞抗原II类基因型不影响多发性硬化症患者的髓鞘反应性。
Cells. 2020 Dec 17;9(12):2703. doi: 10.3390/cells9122703.
3
Epitope prediction and identification- adaptive T cell responses in humans.
表位预测和鉴定——人类适应性 T 细胞反应。
Semin Immunol. 2020 Aug;50:101418. doi: 10.1016/j.smim.2020.101418. Epub 2020 Oct 31.
4
Major Histocompatibility Complex Binding, Eluted Ligands, and Immunogenicity: Benchmark Testing and Predictions.主要组织相容性复合物结合、洗脱配体和免疫原性:基准测试和预测。
Front Immunol. 2020 Feb 5;10:3151. doi: 10.3389/fimmu.2019.03151. eCollection 2019.
5
Human Leukocyte Antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 Present Complementary Peptide Repertoires.人类白细胞抗原(HLA)-DRB1*15:01和HLA-DRB5*01:01呈现互补的肽库。
Front Immunol. 2017 Aug 21;8:984. doi: 10.3389/fimmu.2017.00984. eCollection 2017.
6
A cell-based high-throughput screening assay system for inhibitor compounds of antigen presentation by HLA class II molecule.基于细胞的 HLA Ⅱ类分子呈递抗原抑制剂化合物的高通量筛选检测系统。
Sci Rep. 2017 Jul 28;7(1):6798. doi: 10.1038/s41598-017-07080-4.
7
Unconventional T-cell recognition of an arthritogenic epitope of proteoglycan aggrecan released from degrading cartilage.从降解软骨中释放的蛋白聚糖聚集蛋白聚糖的致关节炎表位的非常规T细胞识别。
Immunology. 2016 Apr;147(4):389-98. doi: 10.1111/imm.12557. Epub 2015 Dec 21.
8
Homo-β-amino acid containing MBP(85-99) analogs alleviate experimental autoimmune encephalomyelitis.含人β-氨基酸的髓鞘碱性蛋白(85-99)类似物可减轻实验性自身免疫性脑脊髓炎。
Sci Rep. 2015 Feb 3;5:8205. doi: 10.1038/srep08205.
9
A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.一种广泛涵盖常见于普通人群中的 DR、DP 和 DQ 等位基因变体的 HLA Ⅱ类限制的确定策略。
Immunogenetics. 2013 May;65(5):357-70. doi: 10.1007/s00251-013-0684-y. Epub 2013 Feb 8.
10
Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.通过凝胶过滤或单克隆抗体捕获来测量MHC/肽相互作用。
Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.. doi: 10.1002/0471142735.im1803s100.